13F Data
13F filer · CIK 1569064

MONTANOVA CAPITAL, LLC

New York, NY · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$5.5B
+$1.6B vs prior
Positions
96
New / sold out
21 / 14
Added / reduced
26 / 17
Turnover
12.6%
buys $1.2B · sells $589.6M
Top-10 weight
49.1%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedSPYSTATE STR SPDR S&P 500 ETF TPUT+600,000+171.4%+$448.1M
NewAVALYN PHARMACEUTICALS INC+2,503,109–+$82.4M
NewHUT 8 CORP+670,000–+$77.3M
AddedFAETH THERAPEUTICS INC+1,985,554+5747.1%+$49.6M
NewAMPHENOL CORP+269,300–+$47.5M
AddedSPOTIFY TECHNOLOGY S A+100,700+9154.5%+$46.2M
NewROUNDHILL ETF TRUST+603,000–+$44.5M
NewCEREBRAS SYSTEMS INC+171,900–+$38.0M
NewDICKS SPORTING GOODS INC+151,320–+$34.3M
AddedINFLARX NV+15,000,000+189.1%+$33.6M
37 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outAPELLIS PHARMACEUTICALS INC-3,518,471-100.0%$-141.5M
Sold outKALVISTA PHARMACEUTICALS INC-4,768,712-100.0%$-96.0M
Sold outERASCA INC-3,434,967-100.0%$-55.6M
ReducedPERFORMANCE FOOD GROUP CO-372,175-96.2%$-41.6M
ReducedUS FOODS HLDG CORP-389,050-98.3%$-39.8M
ReducedMINERALYS THERAPEUTICS INC-1,364,776-88.7%$-36.8M
ReducedBACBANK OF AMER CORP-505,525-39.0%$-28.8M
ReducedMONTE ROSA THERAPEUTICS INC-677,270-16.0%$-16.4M
ReducedUNITEDHEALTH GROUP INC-36,500-36.3%$-15.2M
ReducedLEGEND BIOTECH CORP-511,029-6.7%$-14.8M
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $746.1MQ1 2014: $840.4MQ2 2014: $1.1BQ3 2014: $1.1BQ4 2014: $1.4BQ1 2015: $1.7BQ2 2015: $2.1BQ3 2015: $943.4MQ4 2015: $2.0BQ1 2016: $2.6BQ2 2016: $2.6BQ3 2016: $3.1BQ4 2016: $3.9BQ1 2017: $3.2BQ2 2017: $3.2BQ3 2017: $3.5BQ4 2017: $4.2BQ1 2018: $4.0BQ2 2018: $3.8BQ3 2018: $4.3BQ4 2018: $1.7BQ1 2019: $3.5BQ2 2019: $4.7BQ3 2019: $3.9BQ4 2019: $4.4BQ1 2020: $3.7BQ2 2020: $4.7BQ3 2020: $5.6BQ4 2020: $7.0BQ1 2021: $6.8BQ2 2021: $6.7BQ3 2021: $5.9BQ4 2021: $5.2BQ1 2022: $3.3BQ2 2022: $2.6BQ3 2022: $2.4BQ4 2022: $2.4BQ1 2023: $2.4BQ2 2023: $1.9BQ3 2023: $1.9BQ4 2023: $2.2BQ1 2024: $2.7BQ2 2024: $2.7BQ3 2024: $3.1BQ4 2024: $2.9BQ1 2025: $2.7BQ2 2025: $3.3BQ3 2025: $3.9BQ4 2025: $4.9BQ1 2026: $3.9BQ2 2026: $5.5B
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SPYSTATE STR SPDR S&P 500 ETF TPUT950,000$709.4M12.97%
2VERADERMICS INCCOMMON STOCK4,168,970$512.5M9.37%
3ARCUTIS BIOTHERAPEUTICS INCCOM12,437,000$326.1M5.96%
4LEGEND BIOTECH CORPSPONSORED ADS7,070,000$204.2M3.73%
5PALVELLA THERAPEUTICS INC NECOM1,135,406$173.5M3.17%
6ARRIVENT BIOPHARMA INCCOM4,515,531$156.9M2.87%
7BENITEC BIOPHARMA INCCOM NEW11,548,351$154.5M2.83%
8BIOHAVEN LTDCOM10,286,937$153.1M2.80%
9ADVANCED MICRO DEVICES INCCOM257,240$149.4M2.73%
10ARCUS BIOSCIENCES INCCOM4,776,423$147.3M2.69%
86 more rows. Subscribe for $29/month to see every row, download the data and use the API.